Veritable, L.P. Gilead Sciences, Inc. Transaction History

Veritable, L.P.

$0
Q3 2023

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $91,288 - $104,126	-1,201 Reduced 3.27%	35,530 $2.74 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $33,552 - $38,226	434 Added 1.2%	36,731 $3.05 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $230,708 - $331,217	3,702 Added 11.36%	36,297 $3.12 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $30,782 - $35,161	517 Added 1.61%	32,595 $2.01 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $46,695 - $52,593	809 Added 2.59%	32,078 $1.98 Million
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $69,214 - $86,733	-1,195 Reduced 3.68%	31,269 $1.86 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $110,944 - $125,924	1,710 Added 5.56%	32,464 $2.36 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $25,586 - $27,605	378 Added 1.24%	30,754 $2.15 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $18,215 - $19,903	287 Added 0.95%	30,376 $2.09 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $43,860 - $50,044	731 Added 2.49%	30,089 $1.95 Million
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $594,825 - $677,775	-10,500 Reduced 26.34%	29,358 $1.71 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $61,789 - $77,689	-995 Reduced 2.44%	39,858 $2.52 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $204,215 - $237,132	-2,823 Reduced 6.46%	40,853 $3.14 Million
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $69,080 - $88,482	1,103 Added 2.59%	43,676 $3.27 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $125,704 - $138,271	2,040 Added 5.03%	42,573 $2.77 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $43,194 - $47,679	691 Added 1.73%	40,533 $2.57 Million
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $16,828 - $18,871	272 Added 0.69%	39,842 $2.69 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $5,002 - $5,604	-80 Reduced 0.2%	39,570 $2.57 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $123,259 - $160,844	-2,036 Reduced 4.88%	39,650 $2.48 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $57,309 - $63,451	-804 Reduced 1.89%	41,686 $3.22 Million
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $271,263 - $316,418	-4,181 Reduced 8.96%	42,490 $3.01 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $121,642 - $148,296	-1,670 Reduced 3.45%	46,671 $3.52 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $580,939 - $681,940	-8,165 Reduced 14.45%	48,341 $3.46 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $4.07 Million - $4.83 Million	56,506	56,506 $4.58 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Veritable, L.P. with notifications on news.

Account